Skip to main content
Search
Site Search
Canada | en
Choose location
|
English
Français
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Mexico |
es
United States |
en
Venezuela |
es
Australia |
en
Hong Kong S.A.R. |
zh
India |
en
Indonesia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Malaysia |
en
Philippines |
en
Singapore |
en
Taiwan |
zh
Austria |
de
Belgium |
fr
Belgium |
nl
Bulgaria |
bg
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hungary |
hu
Ireland |
en
Italy |
it
Latvia |
lv
Lithuania |
lt
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Ukraine |
українська
United Kingdom |
en
Global |
en
Novartis Foundation |
en
Egypt |
en
Israel |
he
South Africa |
en
Turkey |
tr
Canada
Choose location
English
Français
americas
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Belgium |
fr
Belgium |
nl
Brazil |
pt
Bulgaria |
bg
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Egypt |
en
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Global |
en
Greece |
el
Hong Kong S.A.R. |
zh
Hungary |
hu
India |
en
Indonesia |
en
Ireland |
en
Israel |
he
Italy |
it
Japan |
ja
Korea |
ko
Latvia |
lv
Lithuania |
lt
Mainland China |
zh
Malaysia |
en
Mexico |
es
Netherlands |
nl
Norway |
no
Novartis Foundation |
en
Philippines |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Singapore |
en
Slovakia |
sk
South Africa |
en
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Taiwan |
zh
Turkey |
tr
Ukraine |
українська
United Kingdom |
en
United States |
en
Venezuela |
es
Menu
About
Novartis in Canada
Diversity, Equity and Inclusion
Executive Committee
People and Culture
Therapeutic Areas
Products
Our people Stories
Contact Us
About
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Adverse Event Reporting
Diseases
Patient perspective Stories
Grants and Donations
Patients and Caregivers
Healthcare Professionals
HCP Portal
Products
Pipeline (EN)
Adverse Event Reporting
Clinical Trials
Novartis Clinical Trials
Disclosure Of Payments To Healthcare Professionals
Healthcare Professionals
ESG
Access
Ethics, Risk and Compliance
Grants and Donations
Health Equity Initiative
Guidelines and Eligibility Criteria
About the Novartis Health Equity Initiative
Past Winners
Online Application
Corporate Responsibility
AODA Compliant - EN (PDF 0.2 MB)
AODA Compliant - FR (PDF 0.2 MB)
AMA Compliant - EN (PDF 0.2 MB)
AMA Compliant - FR (PDF 0.2 MB)
Disclosure Of Payments To Healthcare Professionals
Environmental Sustainability
Reporting and Transparency Hub
ESG
News
News Archive
Our people Stories
Website Privacy Policy
General Privacy Notice for Business Partners
General Privacy Notice for Third Parties
General Privacy Notice for External Stakeholders
Privacy Notice for Pharmacovigilance, Medical Information, and Product Quality Complaints
Careers
Diversity, Equity and Inclusion
People and Culture
Career Search
How We Work
Well-being
Careers
Contact Us
Header
Media Contacts
For journalists with a media inquiry, please contact us:
Corporate Communications
Novartis Canada
Phone:
514-633-7873
E-mail:
[email protected]
Share
Tweet
Share
Whatsapp
Linkedin
Email
Printable Links Block (Content)
Print
PDF